Japan's Kobayashi Acquires Alva-Amco To Expand In US
By acquiring Illinois' Alva-Amco, Japan's Kobayashi is hoping to take its US consumer business, and brands such as Zim's Max, to the next level.
You may also be interested in...
RB CEO Laxman Narasimhan sees the potential for the company to establish a global supplements business built on the successes it has enjoyed in the US and China. The comments came as RB reported solid growth in the third quarter, despite struggles for its OTC brands.
Bayer invests $8m in medical dermatology specialist Azitra to advance development of OTC and cosmetic products harnessing the skin microbiome.
Teva subsidiary Ratiopharm has secured EMA backing for the EU-wide switch of allergy drug desloratadine.